Latest filing published 03 Jan 2025 for AIM ImmunoTech Inc., €1,668. Read the official filing
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Stewart Appelrouth discloses dealings in AIM ImmunoTech Inc. to SEC (Form 4). Over a trading history stretching from 24 November 2021 to 31 December 2024, the count stands at 10 filings.
Purchases make up the whole of the open-market record (4 purchases, €66k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 5 share grants.
The median purchase comes to €19k. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
On 3 January 2025 came the latest disclosure, a share grant for €1,668 in AIM ImmunoTech Inc. The last purchase on record was published on 4 December 2024, which is 683 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations